JPRN-UMIN000002957已完成2 期
INtraPeritoneal Administration of ChemoTherapeutic agent Trial - INPACT trial
on profit organization ECRI0 个研究点目标入组 100 人开始时间: 2009年12月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
Intraperitoneal administration of paclitaxel was safely conducted with minimal adverse events. However, there was no significant difference in progression-free survival and overall survival between the two arms.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Serious cardiac, hepatic, and pulmonary comorbidities or uncontrollable diabetes mellitus. Active gastrointestinal bleeding or bowel obstruction 2) Active second malignancy either found simultaneously or within 5 years from the diagnosis of gastric cancer 3) Suffering from infection 4) Under steroid therapy 5) Has wishes to become pregnant 6) Under mental disorder 7) allergy to the ingredients of paclitaxel injection 8) severe drug allergy 9) Peripheral neural disorder
研究者
相似试验
尚未招募
Unknown
Phase 3 study of Paclitaxel therapy and monolithic systemic chemotherapy in patients with gastric cancer and gastroesophageal border cancer with peritoneal metastasisNeoplasmsKCT0009110Koera University Guro Hospital117
招募中
2 期
Intraperitoneal and intravenous paclitaxel plus S-1Gastric cancer with peritoneal metastasis or positive peritoneal cytology.JPRN-jRCTs061180008Fujiwara Yoshiyuki50
招募中
不适用
Safety and Efficacy of Bidirectional(Intraperitoneal and systemic) chemotherapy for advanced gastric cancer patients with peritoneal metastasisNeoplasmsKCT0003187Seoul National University Bundang Hospital43
已完成
1 期
Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intakegastric cancer with peritoneal metastasisJPRN-UMIN000019206The University of Tokyo34
招募中
1 期
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal AdenocarcinomaMetastatic Appendiceal AdenocarcinomaIntraperitoneal PaclitaxelNCT06207305M.D. Anderson Cancer Center39